Literature DB >> 21182088

Borrelia species induce inflammasome activation and IL-17 production through a caspase-1-dependent mechanism.

Marije Oosting1, Frank L van de Veerdonk, Thirumala-Devi Kanneganti, Patrick Sturm, Ineke Verschueren, Anneleen Berende, Jos W M van der Meer, Bart-Jan Kullberg, Mihai G Netea, Leo A B Joosten.   

Abstract

Borrelia burgdorferi spirochetes cause Lyme disease, which can result in severe clinical symptoms such as multiple joint inflammation and neurological disorders. IFN-γ and IL-17 have been suggested to play an important role in the host defense against Borrelia, and in the immunopathology of Lyme disease. The caspase-1-dependent cytokine IL-1β has been linked to the generation of IL-17-producing T cells, whereas caspase-1-mediated IL-18 is crucial for IFN-γ production. In this study, we show by using knockout mice the role of inflammasome-activated caspase-1 in the regulation of cytokine responses by B. burgdorferi. Caspase-1-deficient cells showed significantly less IFN-γ and IL-17 production after Borrelia stimulation. A lack of IL-1β was responsible for the defective IL-17 production, whereas IL-18 was crucial for the IFN-γ production. Caspase-1-dependent IL-33 played no role in the Borrelia-induced production of IL-1β, IFN-γ or IL-17. In conclusion, we describe for the first time the role of the inflammasome-dependent caspase-1 activation of cytokines in the regulation of IL-17 production induced by Borrelia spp. As IL-17 has been implicated in the pathogenesis of chronic Lyme disease, these data suggest that caspase-1 targeting may represent a new immunomodulatory strategy for the treatment of complications of late stage Lyme disease.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21182088      PMCID: PMC3939779          DOI: 10.1002/eji.201040385

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  51 in total

Review 1.  Overview of interleukin-18: more than an interferon-gamma inducing factor.

Authors:  C A Dinarello; D Novick; A J Puren; G Fantuzzi; L Shapiro; H Mühl; D Y Yoon; L L Reznikov; S H Kim; M Rubinstein
Journal:  J Leukoc Biol       Date:  1998-06       Impact factor: 4.962

2.  Association of CD4+ CD25+ T cells with prevention of severe destructive arthritis in Borrelia burgdorferi-vaccinated and challenged gamma interferon-deficient mice treated with anti-interleukin-17 antibody.

Authors:  Dean T Nardelli; Matthew A Burchill; Douglas M England; Jose Torrealba; Steven M Callister; Ronald F Schell
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

3.  Response to local inflammation of IL-1 beta-converting enzyme- deficient mice.

Authors:  G Fantuzzi; G Ku; M W Harding; D J Livingston; J D Sipe; K Kuida; R A Flavell; C A Dinarello
Journal:  J Immunol       Date:  1997-02-15       Impact factor: 5.422

4.  Experimental lyme arthritis in the absence of interleukin-4 or gamma interferon.

Authors:  C R Brown; S L Reiner
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

5.  Defective NK cell activity and Th1 response in IL-18-deficient mice.

Authors:  K Takeda; H Tsutsui; T Yoshimoto; O Adachi; N Yoshida; T Kishimoto; H Okamura; K Nakanishi; S Akira
Journal:  Immunity       Date:  1998-03       Impact factor: 31.745

6.  Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf.

Authors:  Sanjeev Mariathasan; Kim Newton; Denise M Monack; Domagoj Vucic; Dorothy M French; Wyne P Lee; Meron Roose-Girma; Sharon Erickson; Vishva M Dixit
Journal:  Nature       Date:  2004-06-09       Impact factor: 49.962

7.  Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme.

Authors:  K Kuida; J A Lippke; G Ku; M W Harding; D J Livingston; M S Su; R A Flavell
Journal:  Science       Date:  1995-03-31       Impact factor: 47.728

8.  Association between different clinical manifestations of Lyme disease and different species of Borrelia burgdorferi sensu lato.

Authors:  T Balmelli; J C Piffaretti
Journal:  Res Microbiol       Date:  1995-05       Impact factor: 3.992

9.  Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections.

Authors:  M G Netea; P N Demacker; B J Kullberg; O C Boerman; I Verschueren; A F Stalenhoef; J W van der Meer
Journal:  J Clin Invest       Date:  1996-03-15       Impact factor: 14.808

10.  Borrelia burgdorferi activates a T helper type 1-like T cell subset in Lyme arthritis.

Authors:  H Yssel; M C Shanafelt; C Soderberg; P V Schneider; J Anzola; G Peltz
Journal:  J Exp Med       Date:  1991-09-01       Impact factor: 14.307

View more
  23 in total

1.  Infection of Interleukin 17 Receptor A-Deficient C3H Mice with Borrelia burgdorferi Does Not Affect Their Development of Lyme Arthritis and Carditis.

Authors:  Carrie E Lasky; Kara E Jamison; Darcie R Sidelinger; Carmela L Pratt; Guoquan Zhang; Charles R Brown
Journal:  Infect Immun       Date:  2015-05-04       Impact factor: 3.441

2.  Interleukin-35 enhances Lyme arthritis in Borrelia-vaccinated and -infected mice.

Authors:  Joseph Kuo; Dean T Nardelli; Thomas F Warner; Steven M Callister; Ronald F Schell
Journal:  Clin Vaccine Immunol       Date:  2011-05-25

3.  MyD88 Signaling in T Cells Is Critical for Effector CD4 T Cell Differentiation following a Transitional T Follicular Helper Cell Stage.

Authors:  Rajakumar Mandraju; Aakanksha Jain; Yajing Gao; Zhiming Ouyang; Michael V Norgard; Chandrashekhar Pasare
Journal:  Infect Immun       Date:  2018-04-23       Impact factor: 3.441

4.  TRIF mediates Toll-like receptor 2-dependent inflammatory responses to Borrelia burgdorferi.

Authors:  Tanja Petnicki-Ocwieja; Erin Chung; David I Acosta; Laurie T Ramos; Ok S Shin; Sanjukta Ghosh; Lester Kobzik; Xin Li; Linden T Hu
Journal:  Infect Immun       Date:  2012-11-19       Impact factor: 3.441

5.  NLRP3 inflammasome activation and interleukin-1β release in macrophages require calcium but are independent of calcium-activated NADPH oxidases.

Authors:  Balázs Rada; Jonathan J Park; Payel Sil; Miklós Geiszt; Thomas L Leto
Journal:  Inflamm Res       Date:  2014-07-22       Impact factor: 4.575

6.  The inflammasome drives protective Th1 and Th17 cellular responses in disseminated candidiasis.

Authors:  Frank L van de Veerdonk; Leo A B Joosten; Patrick J Shaw; Sanne P Smeekens; R K Subbarao Malireddi; Jos W M van der Meer; Bart-Jan Kullberg; Mihai G Netea; Thirumala-Devi Kanneganti
Journal:  Eur J Immunol       Date:  2011-07-04       Impact factor: 5.532

7.  Role of interleukin-23 (IL-23) receptor signaling for IL-17 responses in human Lyme disease.

Authors:  Marije Oosting; Hadewych ter Hofstede; Frank L van de Veerdonk; Patrick Sturm; Bart-Jan Kullberg; Jos W M van der Meer; Mihai G Netea; Leo A B Joosten
Journal:  Infect Immun       Date:  2011-09-06       Impact factor: 3.441

Review 8.  Targeting inflammasomes in rheumatic diseases.

Authors:  Alexander So; Annette Ives; Leo A B Joosten; Nathalie Busso
Journal:  Nat Rev Rheumatol       Date:  2013-05-14       Impact factor: 20.543

9.  Macrophage mediated recognition and clearance of Borrelia burgdorferi elicits MyD88-dependent and -independent phagosomal signals that contribute to phagocytosis and inflammation.

Authors:  Sarah J Benjamin; Kelly L Hawley; Paola Vera-Licona; Carson J La Vake; Jorge L Cervantes; Yijun Ruan; Justin D Radolf; Juan C Salazar
Journal:  BMC Immunol       Date:  2021-05-17       Impact factor: 3.615

10.  Murine Borrelia arthritis is highly dependent on ASC and caspase-1, but independent of NLRP3.

Authors:  Marije Oosting; Kathrin Buffen; Subbarao R K Malireddi; Patrick Sturm; Ineke Verschueren; Marije I Koenders; Frank L van de Veerdonk; Jos W M van der Meer; Mihai G Netea; Thirumala-Devi Kanneganti; Leo A B Joosten
Journal:  Arthritis Res Ther       Date:  2012-11-13       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.